SMTL ID : 8av1.1

Crystal structure of GSK3 beta (GSK3b) in complex with CD7.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

homo-dimer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: R.71, R.155, K.180, N.188, V.189 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.189 Salt bridges: A:R.71, A:R.155, A:K.180 SO4.7: 5 residues within 4Å: Chain B: R.71, R.155, K.180, N.188, V.189 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:V.189 Salt bridges: B:R.71, B:R.155, B:K.180

7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 7 residues within 4Å: Chain A: Y.31, T.34, Y.46, I.59, K.61, S.93, N.104 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.93, A:S.93 EDO.3: 6 residues within 4Å: Chain A: H.81, C.82, R.142, N.336, T.338, E.341 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:C.82, A:R.142, A:T.338 EDO.4: 6 residues within 4Å: Chain A: Y.115, R.119, S.122, E.224, G.228, Q.229 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.122, A:E.224 Water bridges: A:G.228 EDO.5: 5 residues within 4Å: Chain A: T.113, Q.160, N.161, C.174 Ligands: O9L.6 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.161 Water bridges: A:T.113 EDO.8: 5 residues within 4Å: Chain B: T.113, Q.160, N.161, C.174 Ligands: O9L.11 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:N.161 Water bridges: B:T.113, B:T.113 EDO.9: 5 residues within 4Å: Chain B: A.118, S.122, E.224, G.228, Q.229 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.122, B:E.224 EDO.10: 3 residues within 4Å: Chain B: P.275, W.276, T.277 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:W.276, B:T.277, B:T.277

2 x O9L: 2-pyridin-3-yl-8-thiomorpholin-4-yl-[1,3]oxazolo[5,4-f]quinoxaline(Non-covalent)

O9L.6: 18 residues within 4Å: Chain A: I.37, F.42, V.45, A.58, K.60, V.85, L.107, D.108, Y.109, V.110, P.111, E.112, T.113, R.116, L.163, C.174, D.175 Ligands: EDO.5 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.42, A:V.45, A:A.58, A:V.85, A:L.163 Hydrogen bonds: A:V.110 Water bridges: A:D.175 O9L.11: 16 residues within 4Å: Chain B: I.37, F.42, V.45, A.58, K.60, V.85, L.107, D.108, Y.109, V.110, P.111, T.113, R.116, L.163, D.175 Ligands: EDO.8 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:F.42, B:V.45, B:A.58, B:V.85, B:L.107, B:L.163 Hydrogen bonds: B:V.110 Water bridges: B:K.60, B:D.175

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hasyeoui, M. et al., Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3 alpha (GSK-3 alpha ): Development and impact on temozolomide treatment of glioblastoma cells. Bioorg.Chem. (2023)

Release Date

2023-04-19

Peptides

Glycogen synthase kinase-3 beta: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Glycogen synthase kinase-3 beta

Related Entries With Identical Sequence